Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622399 · ClinicalTrials.gov registry record · NA
Mobilizing Community Networks to Optimize Child Well-being
A NA study of Social Isolation, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT02622399: Completed NA study of Social Isolation, sponsored by Boston Medical Center.
NCT02622399 is a NA study of Social Isolation that has completed, run by Boston Medical Center. The registered enrollment target is 98 participants, below the 200-participant average among 24 other Social Isolation trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02622399, a NA study of Social Isolation, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
Caregiver social isolation adversely impacts child health and developmental outcomes; it also contributes to suboptimal engagement in health care services and enrichment resources, which also elevate risk for poor outcomes in childhood. The proposed pilot intervention aims to reduce social isolation and promote engagement in health promoting enrichment and activities, by embedding a community health worker assisted forum in a community-driven mobile communications (using a platform supported by the company txtwire). The investigators propose a two-arm, pilot study enrolling 100 parents of children age 0-5 years old who reside in the Roxbury, Dorchester, and Mattapan neighborhoods of Boston. Participants will be recruited from Boston Medical Center and community sites in Roxbury, Dorchester, and Mattapan. The investigators will use quality improvement methods to improve the utilization of the mobile communications shared through txtwire to build collective efficacy for children and social support and engagement that will optimize family resiliency and thereby promote child well-being, as well as, assess the acceptability of the intervention, and logistics of the field implementation to ultimately inform an appropriately powered RCT. Participants will receive compensation for participation at baseline and follow-up interviews. The intent of this study is to support developement of mobile social communications to reduce social isolation.
Primary Outcome
This will be measured by change in baseline to follow-up survey on measures of social isolation.
Conditions Studied
Interventions
- BEHAVIORAL Project NOW
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2017-06-01 |
| Phase | NA |
What the finished NCT02622399 record still lists
NCT02622399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 200-participant average among 24 other Social Isolation trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Social Isolation appearing as the primary indexed condition, and to 1 intervention - of which Project NOW is the first listed.
NCT02622399 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02622399 about?
NCT02622399 is a clinical study titled "Mobilizing Community Networks to Optimize Child Well-being". Caregiver social isolation adversely impacts child health and developmental outcomes; it also contributes to suboptimal engagement in health care services and enrichment resources, which also elevate risk for poor outcomes in childhood. The proposed pilot intervention aims to reduce social isolation...
What is the current status of trial NCT02622399?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2015-08-01. Estimated completion is 2017-06-01.
What conditions does trial NCT02622399 study?
This clinical trial studies the following conditions: Social Isolation.
What interventions are being tested in trial NCT02622399?
The interventions under investigation include: Project NOW (BEHAVIORAL).
Who is sponsoring clinical trial NCT02622399?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02622399 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Isolation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02622399's enrollment target sits among peer trials
98 14th of 24 higher than 11 of 24 other Social Isolation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Social Isolation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Qnnections: Refinement and Pilot Trial of a Suicide Prevention Intervention to Increase Social Connection
RECRUITING · NA
-
Need to be Needed (N2BN) Intervention
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
-
Intervening on Opioid Use and Loneliness
RECRUITING · NA
-
LEAPTogether: An Intergenerational Intervention to Address Loneliness and Social Isolation
RECRUITING · NA
-
Fostering Agricultural Relationships and Meaning - Thriving on Kinship
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI